Guiqiang Wang

721 total citations
17 papers, 490 citations indexed

About

Guiqiang Wang is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Guiqiang Wang has authored 17 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 11 papers in Hepatology and 2 papers in Molecular Biology. Recurrent topics in Guiqiang Wang's work include Hepatitis B Virus Studies (12 papers), Hepatitis C virus research (11 papers) and Liver Disease Diagnosis and Treatment (9 papers). Guiqiang Wang is often cited by papers focused on Hepatitis B Virus Studies (12 papers), Hepatitis C virus research (11 papers) and Liver Disease Diagnosis and Treatment (9 papers). Guiqiang Wang collaborates with scholars based in China, United Kingdom and United States. Guiqiang Wang's co-authors include Zhongping Duan, Hong Ren, Fengmin Lu, Fu‐Sheng Wang, Jian Sun, Jinlin Hou, Jidong Jia, Hong Tang, Qing Xie and Hui Zhuang and has published in prestigious journals such as Nature Communications, PLoS ONE and Medicine.

In The Last Decade

Guiqiang Wang

16 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guiqiang Wang China	10	405	335	49	38	38	17	490
Honglian Gui China	13	340 0.8×	306 0.9×	55 1.1×	51 1.3×	107 2.8×	27	494
Yanhang Gao China	9	176 0.4×	170 0.5×	43 0.9×	34 0.9×	81 2.1×	20	306
Chih‐Feng Wu Taiwan	9	330 0.8×	266 0.8×	78 1.6×	46 1.2×	46 1.2×	9	451
Suzanne Faure‐Dupuy France	8	284 0.7×	224 0.7×	62 1.3×	49 1.3×	112 2.9×	13	377
Till Bornscheuer Germany	5	335 0.8×	297 0.9×	41 0.8×	54 1.4×	42 1.1×	8	383
Lingyao Du China	12	314 0.8×	286 0.9×	119 2.4×	51 1.3×	55 1.4×	60	489
Zunaira Awan Pakistan	10	261 0.6×	277 0.8×	39 0.8×	49 1.3×	22 0.6×	15	343
Yongbin Zeng China	11	222 0.5×	147 0.4×	121 2.5×	52 1.4×	31 0.8×	31	330
Watcharasak Chotiyaputta Thailand	13	555 1.4×	546 1.6×	22 0.4×	106 2.8×	15 0.4×	30	623
Omar Galdame Argentina	14	332 0.8×	336 1.0×	37 0.8×	32 0.8×	49 1.3×	39	450

Countries citing papers authored by Guiqiang Wang

Since Specialization

Citations

This map shows the geographic impact of Guiqiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiqiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiqiang Wang more than expected).

Fields of papers citing papers by Guiqiang Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guiqiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiqiang Wang. The network helps show where Guiqiang Wang may publish in the future.

Co-authorship network of co-authors of Guiqiang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Guiqiang Wang. A scholar is included among the top collaborators of Guiqiang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guiqiang Wang. Guiqiang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Li, Bao, Baobao Lin, Yan Wang, et al.. (2024). Multi-scenario surveillance of respiratory viruses in aerosols with sub-single-copy spatial resolution. Nature Communications. 15(1). 8770–8770. 12 indexed citations

Zhang, Junchang, et al.. (2023). High-potency nucleos(t)ide analogues alone or plus immunoglobulin for HBV prophylaxis after liver transplantation: a meta-analysis. Hepatology International. 17(5). 1113–1124.

Li, Jun, Zhanqing Zhang, Weifeng Zhao, et al.. (2023). Factors associated with persistent positive in HBV DNA level in patients with chronic Hepatitis B receiving entecavir treatment. Frontiers in Cellular and Infection Microbiology. 13. 1151899–1151899. 3 indexed citations

Mao, Jing, et al.. (2022). Hypoxia-induced interstitial transformation of microvascular endothelial cells by mediating HIF-1α/VEGF signaling in systemic sclerosis. PLoS ONE. 17(3). e0263369–e0263369. 20 indexed citations

Li, Miaomiao, Lan Mi, Xinqiang Ji, et al.. (2022). Effect of infection with hepatitis B virus on the survival outcome of diffuse large B-cell lymphoma in the prophylactic antiviral era. Frontiers in Oncology. 12. 989258–989258. 1 indexed citations

Liang, Xieer, Qing Xie, Jia Shang, et al.. (2021). Tenofovir disoproxil fumarate for multiple nucleos(t)ide analogues treatment failure hepatitis B: Is monotherapy enough?. Journal of Gastroenterology and Hepatology. 37(3). 471–479. 2 indexed citations

Wang, Guiqiang & Zhongping Duan. (2021). Guidelines for Prevention and Treatment of Chronic Hepatitis B. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 62 indexed citations

Chen, Xiabing, Guiqiang Wang, Lijun Wu, et al.. (2021). A survey of <i>Prototheca bovis</i> infection in dairy farms of the Hubei province, China. Journal of Veterinary Medical Science. 83(8). 1248–1255. 7 indexed citations

Sun, Jian, Bin Zhou, Qing Xie, et al.. (2020). A missense variant in complement factor B (CFB) is a potential predictor of 24‐week off‐treatment response to PegIFNα therapy in Chinese HBeAg‐positive chronic hepatitis B patients. Alimentary Pharmacology & Therapeutics. 51(4). 469–478. 14 indexed citations

10.

Liu, Jinfeng, Tianyan Chen, Yaolong Chen, et al.. (2020). 2019 Chinese Clinical Practice Guidelines for the Prevention of Mother-to-child Transmission of Hepatitis B Virus. Journal of Clinical and Translational Hepatology. 8(4). 1–10. 9 indexed citations

11.

Zhang, Min, Guangdi Li, Jia Shang, et al.. (2020). Rapidly decreased HBV RNA predicts responses of pegylated interferons in HBeAg-positive patients: a longitudinal cohort study. Hepatology International. 14(2). 212–224. 25 indexed citations

12.

Ning, Qin, Di Wu, Guiqiang Wang, et al.. (2019). Roadmap to functional cure of chronic hepatitis B: An expert consensus. Journal of Viral Hepatitis. 26(10). 1146–1155. 56 indexed citations

13.

Hou, Jinlin, Guiqiang Wang, Fu‐Sheng Wang, et al.. (2017). Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update). Journal of Clinical and Translational Hepatology. 5(4). 297–318. 202 indexed citations

14.

Jia, Wei, Liuwei Song, Xiaofeng Wu, et al.. (2014). Antibody to Hepatitis B Core Antigen Levels in the Natural History of Chronic Hepatitis B. Medicine. 93(29). e322–e322. 55 indexed citations

15.

Wang, Guiqiang, Yongqiong Deng, & Feng-Qin Hou. (2014). Overview of drug-induced liver injury in China. Clinical Liver Disease. 4(1). 26–29. 16 indexed citations

16.

Wang, Guiqiang, et al.. (2012). The Feasibility of Remote Sensing Monitoring upon Locust Plagues in China. 1–4. 2 indexed citations

17.

Wu, Xuejie, et al.. (2009). Baseline predictors of virological response for chronic hepatitis B patients. World Journal of Gastroenterology. 15(34). 4311–4311. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact